Research Reports

  • 26 May 2017

    Orphan cancer drugs take up 37% of market share

    Of Orphan Drug designations awarded by the EU, US, and Japanese drug regulators, 37% have been given for the development of oncology products, with oncology having played a major role...

Close
Close
Close

Go Top